Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesSiân Jones, Kenneth W. Kinzler, Elizabeth M. Jaffee et al.|Science|2008Cited by 4k
Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer PatientsAmy Thomas, Elizabeth M. Jaffee|The Journal of Experimental Medicine|2004Cited by 349
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)Dung T. Le, Elizabeth M. Jaffee, Vincent J. Picozzi et al.|Clinical Cancer Research|2019Cited by 260
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M. Jaffee, Richard Sullivan, Chi V. Dang et al.|The Lancet Oncology|2017Cited by 209
Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic CancerLei Zheng, Elizabeth M. Jaffee|PLoS ONE|2011Cited by 183